FDA perspective on assessing the clinical benefit of cardiac resynchronization and implantable cardioverter-defibrillator devices

被引：0
|
作者：
Selzman, Kimberly A. [1 ]
机构：
[1] US FDA, Div Cardiovasc Devices, Off Device Evaluat, Ctr Devices & Radiol Hlth, White Oak Campus,Bldg 66,10903 New Hampshire Ave, Silver Spring, MD 20903 USA
来源：
JOURNAL OF ELECTROCARDIOLOGY | 2018年 / 51卷 / 06期
关键词：
HEART-FAILURE; THERAPY;
D O I：
10.1016/j.jelectrocard.2018.08.024
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：S22 / S24
页数：3
相关论文
共 50 条
  • [21] The implantable cardioverter-defibrillator
    Raj, SR
    Sheldon, RS
    PROGRESS IN CARDIOVASCULAR DISEASES, 2001, 44 (03) : 169 - 194
  • [22] Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation
    Sandner, SE
    Wieselthaler, G
    Zuckermann, A
    Taghavi, S
    Schmidinger, H
    Pacher, R
    Ploner, M
    Laufer, G
    Wolner, E
    Grimm, M
    CIRCULATION, 2001, 104 (12) : I171 - I176
  • [23] Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device
    Francisco, Gregory M.
    Sharma, Saumya
    Dougherty, Anne H.
    Kantharia, Bharat K.
    CARDIOLOGY JOURNAL, 2009, 16 (05) : 473 - 476
  • [24] The implantable cardioverter-defibrillator
    Greene, HL
    CLINICAL CARDIOLOGY, 2000, 23 (05) : 315 - 326
  • [25] Effect of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in patients with an implantable cardioverter-defibrillator
    Arya, A
    Haghjoo, M
    Dehghani, MR
    Alasti, M
    Alizadeh, H
    Kazemi, B
    Sadr-Ameli, MA
    HEART RHYTHM, 2005, 2 (10) : 1094 - 1098
  • [26] The implantable cardioverter-defibrillator
    Groh, WJ
    Foreman, LD
    Zipes, DP
    AMERICAN FAMILY PHYSICIAN, 1998, 57 (02) : 310 - 312
  • [27] Predicting benefit for implantable cardioverter-defibrillator use - Reply
    Redberg, Rita F.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (03): : 287 - 287
  • [28] Electromagnetic interference: Pacemakers, cardiac resynchronization therapy devices, implantable cardioverter–defibrillator
    Nowak B.
    Przibille O.
    Napp A.
    Herzschrittmachertherapie + Elektrophysiologie, 2022, 33 (3) : 297 - 304
  • [29] Facility-Level Variation and Clinical Outcomes in Use of Cardiac Resynchronization Therapy With and Without an Implantable Cardioverter-Defibrillator
    Kramer, Daniel B.
    Normand, Sharon-Lise T.
    Volya, Rita
    Hatfield, Laura A.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2018, 11 (12): : e004763
  • [30] Implantable cardioverter-defibrillator therapy in clinical practice
    Cesario, DA
    Dec, GW
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (08) : 1507 - 1517
12345